HomeALGS • NASDAQ
add
Aligos Therapeutics Inc
Previous close
$8.16
Day range
$7.50 - $8.17
Year range
$7.35 - $30.00
Market cap
23.97M USD
Avg Volume
102.32K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 1.06M | -84.59% |
Operating expense | 6.38M | -31.04% |
Net income | 5.06M | 126.93% |
Net profit margin | 477.00 | 274.80% |
Earnings per share | 0.75 | 106.98% |
EBITDA | -26.16M | -39.61% |
Effective tax rate | 3.60% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 94.54M | 4.07% |
Total assets | 108.81M | 2.53% |
Total liabilities | 41.58M | 13.94% |
Total equity | 67.23M | — |
Shares outstanding | 6.16M | — |
Price to book | 0.75 | — |
Return on assets | -55.79% | — |
Return on capital | -89.63% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | 5.06M | 126.93% |
Cash from operations | -19.49M | -43.16% |
Cash from investing | 39.99M | 59.95% |
Cash from financing | 281.00K | -32.13% |
Net change in cash | 20.78M | 76.08% |
Free cash flow | -8.96M | -39.41% |
About
Founded
2018
Headquarters
Website
Employees
68